TY - JOUR
T1 - Role of hospital volumes in identifying low-performing and high-performing aortic and mitral valve surgical centers in the United States
AU - Khera, Rohan
AU - Pandey, Ambarish
AU - Koshy, Thomas
AU - Ayers, Colby
AU - Nallamothu, Brahmajee K.
AU - Das, Sandeep R
AU - Drazner, Mark H
AU - Jessen, Michael E
AU - Kirtane, Ajay J.
AU - Gardner, Timothy J.
AU - de Lemos, James A
AU - Bhatt, Deepak L.
AU - Kumbhani, Dharam J
N1 - Funding Information:
Funding/Support: Dr Khera is supported by grant 5T32HL125247-02 from the National Heart, Lung, and Blood Institute and by grant UL1TR001105 from the National Center for Advancing Translational Sciences.
Funding Information:
completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Das reported receiving honoraria from and serving as a consultant for Roche Diagnostics. Dr Kirtane reported receiving grants from Medtronic, Abbott Vascular, Boston Scientific, Abiomed, CathWorks, Siemens, Philips, ReCor Medical, and Spectranetics (all outside of the present work). Dr Bhatt reported serving on advisory boards for Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; reported serving on boards of directors for Boston Veterans Affairs Research Institute and the Society of Cardiovascular Patient Care; reported serving as chair of the American Heart Association quality oversight committee; reported serving on data monitoring committees for Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; reported receiving honoraria from the American College of Cardiology, Belvoir Publications, Duke Clinical Research Institute, Harvard Clinical Research Institute, HMP Communications, Journal of the American College of Cardiology, Population Health Research Institute, Slack Publications, Society of Cardiovascular Patient Care, and WebMD; reported serving as deputy editor of Clinical Cardiology; reported serving as chair of the National Cardiovascular Data Registry– Acute Coronary Treatment and Interventions Outcomes Network Registry steering committee and the Veterans Affairs Clinical Assessment Reporting and Tracking research and publications committee; reported receiving research funding from Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, and The Medicines Company; reported receiving royalties from Elsevier; reported serving as a site coinvestigator for Biotronik, Boston Scientific, and St Jude Medical (now Abbott); reported serving as a trustee for the American College of Cardiology; reported performing unfunded research for FlowCo, PLx Pharma, Takeda; and Merck (all outside of the present work). Dr Kumbhani reported receiving research support and honoraria from the American College of Cardiology and reported receiving honoraria from Aralez and Somahlution. No other disclosures were reported.
Publisher Copyright:
© 2017 American Medical Association. All rights reserved.
PY - 2017/12
Y1 - 2017/12
N2 - IMPORTANCE Identifying high-performing surgical valve centers with the best surgical outcomes is challenging. Hospital surgical volume is a frequently used surrogate for outcomes. However, its ability to distinguish low-performing and high-performing hospitals remains unknown. OBJECTIVE To examine the association of hospital procedure volume with hospital performance for aortic and mitral valve (MV) surgical procedures. DESIGN, SETTING, AND PARTICIPANTS Within an all-payer nationally representative data set of inpatient hospitalizations, this study identified 682 unique hospitals performing surgical aortic valve replacement (SAVR) and MV replacement and repair with or without coronary artery bypass grafting (CABG) between 2007 and 2011. Procedural outcomes were further assessed for a 10-year period (2005-2014) to assess representativeness of study period. MAIN OUTCOMES AND MEASURES In-hospital risk-standardized mortality rate (RSMR) calculated using hierarchical models and an empirical Bayesian approach with volume-based shrinkage that allowed for reliability adjustment. RESULTS At 682 US hospitals, 70 295 SAVR, 19 913 MV replacement, and 17 037MV repair procedures were performed between 2007 and 2011, with a median annual volume of 43 (interquartile range [IQR], 23-76) SAVR, 13 (IQR, 6-22) MV replacement, and 9 (IQR, 4-19) MV repair procedures. Of 225 SAVR hospitals in the highest-volume tertile, 34.7%and 36.0% were in the highest-RSMR tertile for SAVR + CABG and isolated SAVR procedures, respectively, while 21.5%and 17.5%of the 228 SAVR hospitals in the lowest-volume tertile were in the lowest respective RSMR tertile. Similarly, 36.8%and 43.5%of hospitals in the highest tertile of volume forMV replacement and repair, respectively, were in the corresponding highest-RSMR tertile, and 17.4%and 11.2%of the low-volume hospitals were in the lowest-RSMR tertile forMV replacement and repair, respectively. There was limited correlation between outcomes for SAVR and MV procedures at an institution. If solely volume-based tertiles were used to categorize hospitals for quality, 44.7%of all valve hospitals would be misclassified (as either low performing or high performing) when assessing performance based on tertiles of RSMR. CONCLUSIONS AND RELEVANCE Hospital procedure volume alone frequently misclassifies hospital performance with regard to risk-standardized outcomes after aortic and MV surgical procedures. Valve surgery quality improvement endeavors should focus on a more comprehensive assessment that includes risk-adjusted outcomes rather than hospital volume alone.
AB - IMPORTANCE Identifying high-performing surgical valve centers with the best surgical outcomes is challenging. Hospital surgical volume is a frequently used surrogate for outcomes. However, its ability to distinguish low-performing and high-performing hospitals remains unknown. OBJECTIVE To examine the association of hospital procedure volume with hospital performance for aortic and mitral valve (MV) surgical procedures. DESIGN, SETTING, AND PARTICIPANTS Within an all-payer nationally representative data set of inpatient hospitalizations, this study identified 682 unique hospitals performing surgical aortic valve replacement (SAVR) and MV replacement and repair with or without coronary artery bypass grafting (CABG) between 2007 and 2011. Procedural outcomes were further assessed for a 10-year period (2005-2014) to assess representativeness of study period. MAIN OUTCOMES AND MEASURES In-hospital risk-standardized mortality rate (RSMR) calculated using hierarchical models and an empirical Bayesian approach with volume-based shrinkage that allowed for reliability adjustment. RESULTS At 682 US hospitals, 70 295 SAVR, 19 913 MV replacement, and 17 037MV repair procedures were performed between 2007 and 2011, with a median annual volume of 43 (interquartile range [IQR], 23-76) SAVR, 13 (IQR, 6-22) MV replacement, and 9 (IQR, 4-19) MV repair procedures. Of 225 SAVR hospitals in the highest-volume tertile, 34.7%and 36.0% were in the highest-RSMR tertile for SAVR + CABG and isolated SAVR procedures, respectively, while 21.5%and 17.5%of the 228 SAVR hospitals in the lowest-volume tertile were in the lowest respective RSMR tertile. Similarly, 36.8%and 43.5%of hospitals in the highest tertile of volume forMV replacement and repair, respectively, were in the corresponding highest-RSMR tertile, and 17.4%and 11.2%of the low-volume hospitals were in the lowest-RSMR tertile forMV replacement and repair, respectively. There was limited correlation between outcomes for SAVR and MV procedures at an institution. If solely volume-based tertiles were used to categorize hospitals for quality, 44.7%of all valve hospitals would be misclassified (as either low performing or high performing) when assessing performance based on tertiles of RSMR. CONCLUSIONS AND RELEVANCE Hospital procedure volume alone frequently misclassifies hospital performance with regard to risk-standardized outcomes after aortic and MV surgical procedures. Valve surgery quality improvement endeavors should focus on a more comprehensive assessment that includes risk-adjusted outcomes rather than hospital volume alone.
UR - http://www.scopus.com/inward/record.url?scp=85040007963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040007963&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2017.4003
DO - 10.1001/jamacardio.2017.4003
M3 - Article
C2 - 29117319
AN - SCOPUS:85040007963
SN - 2380-6583
VL - 2
SP - 1322
EP - 1331
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 12
ER -